Adagio Medical Holdings Inc
Adagio Medical Holdings Inc (ADGM): 7 pipeline candidates · ~10 mo cash runway · 7 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
10.0 months
D/E 5.87 · 0% dilution
Lead: Approved
7 candidates
N/A
N/A
A transparent, data-derived signal for Adagio Medical Holdings Incacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$17.0M
Cash
$12.9M
Quarterly Burn
$4.1M
Runway
10.0 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| company's second generation vclas catheter system | Approved |
| company's second generation vclas catheter system | Approved |
| pfca | Preclinical |
| pulsed field cryoablation | Preclinical |
| vclas cryoablation system | Phase 3 |
| vclas ultra | Preclinical |
| vt cryoablation system | Phase 3 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
21
Total value held
$20.4M
| Holder | Shares | Value |
|---|---|---|
| perceptive advisors llc | 13,657,406 | $15.4M |
| adage capital partners gp, l.l.c. | 1,258,501 | $1.4M |
| adar1 capital management, llc | 1,205,447 | $1.4M |
| alyeska investment group, l.p. | 1,159,615 | $1.3M |
| silverarc capital management, llc | 251,972 | $290K |
| geode capital management, llc | 125,241 | $144K |
| affinity asset advisors, llc | 80,000 | $92K |
| vanguard capital management llc | 79,216 | $91K |
| vanguard fiduciary trust co | 53,782 | $62K |
| granite investment partners, llc | 27,053 | $31K |
Showing top 10 of 21 institutional holders of Adagio Medical Holdings Inc. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Adagio Medical Holdings Inc's pipeline?
Adagio Medical Holdings Inc (ADGM) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Adagio Medical Holdings Inc's lead drug candidate?
Adagio Medical Holdings Inc's most advanced tracked candidate is company's second generation vclas catheter system (Approved).
What is Adagio Medical Holdings Inc's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Adagio Medical Holdings Inc has approximately 10.0 months of cash runway.
What is Adagio Medical Holdings Inc's market capitalization?
Adagio Medical Holdings Inc's market capitalization is approximately $17.0M.
Who is the CEO of Adagio Medical Holdings Inc?
Mr. Todd Usen is the chief executive officer of Adagio Medical Holdings Inc (ADGM).
Get the full picture on Adagio Medical Holdings Inc
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.